For research use only. Not for therapeutic Use.
Ronidazole-d3 is a deuterated form of ronidazole, an antiprotozoal agent used to treat infections caused by protozoa, particularly in veterinary medicine. In this compound, three hydrogen atoms are replaced with deuterium. It functions as an internal standard in mass spectrometry and NMR spectroscopy, enhancing the precision of quantification and structural analysis. In pharmaceutical research, ronidazole-d3 supports studies on drug metabolism, pharmacokinetics, and pharmacodynamics. The deuterium labeling ensures accurate measurements and reliable data, crucial for understanding the drug’s behavior, interactions, and efficacy in various scientific and clinical applications.
Catalog Number | R047741 |
CAS Number | 1015855-87-4 |
Synonyms | 1-(Methyl-d3)-5-nitro-1H-imidazole-2-methanol 2-Carbamate; [1-(Methyl-d3)-5-nitroimidazol-2-yl]methyl Carbamate; 1-(Methyl-d3)-2-carbamoyl-?oxymethyl-5-nitroimidazole; Dugro-d3; MCMN-d3; Ridzol-d3; Ridzol P-d3; Ridzole-d3; Ronida BT-d3; |
Molecular Formula | C6H8N4O4 |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | [5-nitro-1-(trideuteriomethyl)imidazol-2-yl]methyl carbamate |
InChI | InChI=1S/C6H8N4O4/c1-9-4(3-14-6(7)11)8-2-5(9)10(12)13/h2H,3H2,1H3,(H2,7,11)/i1D3 |
InChIKey | PQFRTXSWDXZRRS-FIBGUPNXSA-N |
SMILES | [2H]C([2H])([2H])N1C(=CN=C1COC(=O)N)[N+](=O)[O-] |